Drug development is an incredibly complex and risky endeavor, one that even experienced organizations will fail at more often than they succeed. This program will help you understand how companies structure their efforts and utilize their resources to improve the odds of successful development, and potentially minimize the risks associated with shepherding a new drug candidate through the development process.  At the end of the program, you will be able to explain the phases, major work streams, key players and interrelationships necessary to develop new drugs in the US and Europe, and to expand the life cycle of in-line products.

This eLearning program will take approximately 6.5 hours to complete. It includes six self-paced modules that can be accessed 24 hours a day, 7 days a week. Modules do not have to be taken in one sitting; users can start/stop at any time and begin where they left off. Users will have one year to complete the modules. Continuing education credits are offered for each module.

MODULES INCLUDED

Module 1: Introduction to Drug Development; 

Module 2: Discovery and Pre-Clinical Phases; 

Module 3: Drug Development Phase 1; 

Module 4: Drug Development Phase 2; 

Module 5: Drug Development Phase 3 and Regulatory Review; 

Module 6: Drug Development Phase 4 and Lifecycle Management

Register Here!